Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Conference highlights Biomarker Detection Role for NanoSight

The NanoSight NS500 system like the one being used in Oxford by the Sargent group
The NanoSight NS500 system like the one being used in Oxford by the Sargent group

Abstract:
Researchers from Oxford have recently presented exciting new data applying nanoparticle tracking analysis (NTA) to size and count both cellular microvesicles and exosomes at a low concentration and, when used in conjunction with fluorescent labels, to selectively determine and analyse specific types of vesicle within a complex sample. This took place during a two-day conference in Oxford, "Micro and Nanovesicles in Health and Disease", organised by Dr Paul Harrison from the Oxford Haemophilia & Thrombosis Centre at the Churchill Hospital in Oxford and Ian Sargent, Professor of Reproductive Science in the Nuffield Department of Obstetrics and Gynaecology, University of Oxford.(1)

Conference highlights Biomarker Detection Role for NanoSight

Salisbury, UK | Posted on October 6th, 2010

Most researchers concur that the high levels of microvesicles and/or exosomes are associated with (i.e. potential biomarkers for) thrombotic diseases, cardiovascular disease and some cancers. Leading the research at the Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Professor Ian Sargent says "many cells shed small vesicles in a regulated way which plays a key role in intercellular communication. In general, there are two types of vesicle: microvesicles (100nm - 1 µm in diameter) which directly bud from the plasma membrane and nanovesicles (exosomes 30nm - 100nm) which are released by exocytosis from multivesicular bodies of the endosome. Both are involved in cell signalling. They carry diverse membrane and cytosolic proteins as well as messenger and microRNAs. They can affect the physiology of their target cells in various ways, from inducing intracellular signalling following binding to receptors, to conferring new properties after the acquisition of new receptors, enzymes or genetic material by fusion or endocytosis. They participate in physiological processes including haemostasis and thrombosis, inflammation, immune interactions and angiogenesis.

Continuing, Sargent said: "NanoSight's NTA technique is a major step forward in analytical capability taking the limits of flow cytometry down almost an order of magnitude. It is rapid and, in common with flow cytometry, characterizes polydispersity well."

Also at this conference Edwin van der Pol from the Academic Medical Center at the University of Amsterdam presented a theoretical comparison of analytical techniques for microvesicles and exosomes. This confirmed the advantages of using NTA for studying vesicles sized from 50-400nm. The previously preferred technique was flow cytometry. However, van der Pol concluded this has a practical lower limit of 300nm. Similarly electrozone sensing is not able detect at such small sizes. He added that while Dynamic Light Scattering (DLS) is able to identify very small particles, it generally biases towards large particles in polydisperse samples so this mis-reporting renders it of little value. It is also not able to make concentration measurement.

Jeremy Warren, NanoSight CEO, commented "The work of this important group is a significant milestone for us. It is the first step toward directing NanoSight's capability as a platform for biomarker detection".

In the closing session, Dr Karl Morten, also from University of Oxford, described NanoSight's useful role in rapidly assessing newly developed nanoparticles, as he summarised a range of roles of nanotechnology in drug delivery.

This conference bought together 135 delegates in this rapidly growing area of interest. There were five groups from the UK, Netherlands and USA who have recently added NanoSight's NTA to their characterisation capability.

To learn more about nanoparticle characterization using Nanoparticle Tracking Analysis, NTA, please visit the company website (www.nanosight.com) and register for the latest issue of NanoTrail, the company's electronic newsletter.

Reference:

(1) Nanoparticle Tracking Analysis for the Measurement and Characterisation of Cellular Microvesicles and Nanovesicles, Proc NVTH BSTH 2010

####

About NanoSight Limited
NanoSight Limited, of Salisbury, UK, provides unique nanoparticle characterization technology. “Nanoparticle Tracking Analysis” (NTA) detects and visualizes populations of nanoparticles in liquids down to 10nm (material dependent) and measures the size of each particle from direct observations of diffusion. This particle-by-particle methodology goes beyond traditional light scattering techniques such as Dynamic Light Scattering (DLS), or Photon Correlation Spectroscopy (PCS), in providing high-resolution particle size distributions. Additionally NanoSight measures concentration and validates all data with video of particles moving under Brownian motion.

This characterization information is highly informative in understanding the more complex suspensions in biological systems, hence its wide application in development of drug delivery systems, viral vaccines, the study of toxicology of nanoparticles and their environmental fate and in biomarker detection. This real-time data also provides insight into the kinetics of protein aggregation and other time-dependent phenomena in a quantitative manner, at deeply sub-micron sizes.

NanoSight has more than 250 systems installed worldwide with users including BASF, BP, GlaxoSmithKline, Novartis, 3M Corp., Roche, Solvay and Unilever together with many universities and research institutes. There are currently 100+ third party papers citing NanoSight results, with this reference base growing very rapidly as NanoSight consolidates its key contribution to nanoparticle characterization. For more information, visit the NanoSight website (www.nanosight.com).

For more information, please click here

Contacts:
NanoSight Limited
Minton Park
London Road
Amesbury SP4 7RT
T +44 (0) 1980 676060
F +44 (0) 1980 624703


NetDyaLog Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA
T +44 (0) 1799 521881
M +44 (0) 7843 012997

Copyright © NanoSight Limited

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Sandia researchers make solid ground toward better lithium-ion battery interfaces: Reducing the traffic jam in batteries December 13th, 2017

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Columbia engineers create artificial graphene in a nanofabricated semiconductor structure: Researchers are the first to observe the electronic structure of graphene in an engineered semiconductor; finding could lead to progress in advanced optoelectronics and data processing December 13th, 2017

Academic/Education

Luleå University of Technology is using the Deben CT5000TEC stage to perform x-ray microtomography experiments with the ZEISS Xradia 510 Versa to understand deformation and strain inside inhomogeneous materials November 7th, 2017

Park Systems Announces the Grand Opening of the Park NanoScience Center at SUNY Polytechnic Institute November 3rd, 2017

Two Scientists Receive Grants to Develop New Materials: Chad Mirkin and Monica Olvera de la Cruz recognized by Sherman Fairchild Foundation August 16th, 2017

Moving at the Speed of Light: University of Arizona selected for high-impact, industrial demonstration of new integrated photonic cryogenic datalink for focal plane arrays: Program is major milestone for AIM Photonics August 10th, 2017

Nanomedicine

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy — Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 — December 6th, 2017

Announcements

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

Sandia researchers make solid ground toward better lithium-ion battery interfaces: Reducing the traffic jam in batteries December 13th, 2017

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Columbia engineers create artificial graphene in a nanofabricated semiconductor structure: Researchers are the first to observe the electronic structure of graphene in an engineered semiconductor; finding could lead to progress in advanced optoelectronics and data processing December 13th, 2017

Tools

Perking up and crimping the 'bristles' of polyelectrolyte brushes December 13th, 2017

Untangling DNA: Researchers filter the entropy out of nanopore measurements December 8th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

Researchers advance technique to detect ovarian cancer: Rice, MD Anderson use fluorescent carbon nanotube probes to achieve first in vivo success November 30th, 2017

Events/Classes

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

Arrowhead Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy — Up to 5.0 log10 reduction in HBsAg observed; data presented at HEP DART 2017 — December 6th, 2017

Leti Breakthroughs Point Way to Significant Improvements in SoC Memories December 6th, 2017

NanoSummit in Luxembourg: single wall carbon nanotubes have entered our lives as we approach a nanoaugmented future November 23rd, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project